Search Results - "ICHIKURA, Daisuke"
-
1
Safety of immune checkpoint inhibitors in non-small-cell lung cancer patients with idiopathic interstitial pneumonia: a matched case–control study
Published in Cancer chemotherapy and pharmacology (01-01-2022)“…Purpose The immune checkpoint inhibitor nivolumab is commonly used for non-small-cell lung cancer treatment. Immune checkpoint inhibitors cause immune-related…”
Get full text
Journal Article -
2
Prevention of vasculitis and vascular pain by side route administration of vinorelbine: A case report
Published in Clinical case reports (01-05-2023)“…Key Clinical Message A 49‐year‐old female with non‐small‐cell lung cancer was placed on adjuvant chemotherapy with vinorelbine (25 mg/m2: Day 1.8) and…”
Get full text
Journal Article -
3
Thyroid dysfunction with atezolizumab plus bevacizumab after lenvatinib in hepatocellular carcinoma: A case series
Published in SAGE open medical case reports (01-01-2023)“…Atezolizumab plus bevacizumab is the recommended first-line treatment for unresectable hepatocellular carcinoma, based on guidelines from the Barcelona Clinic…”
Get full text
Journal Article -
4
Effectiveness of corticosteroids on immune checkpoint inhibitor-induced interstitial pneumonia among patients with a history of interstitial pneumonia: A case series
Published in SAGE open medical case reports (01-07-2021)“…There are few reports on the effectiveness of corticosteroids for immune checkpoint inhibitor-induced interstitial pneumonia in patients with a history of…”
Get full text
Journal Article -
5
Five cases of skin desquamation due to bevacizumab combined with docetaxel-carboplatin in ovarian cancer
Published in International cancer conference journal (01-01-2023)“…The standard of care for ovarian cancer chemotherapy is paclitaxel-carboplatin. In Stage III and Stage IV patients, the addition of bevacizumab has been…”
Get full text
Journal Article -
6
Evaluation of the Tolerability of Gemcitabine and Cisplatin Combination Chemotherapy with a Small Quantity of Replacement Fluid for Biliary Tract Cancer
Published in YAKUGAKU ZASSHI (01-07-2020)“…Cisplatin therapy induces kidney injury as a side effect. Thus, replacement fluid must be administered to prevent kidney injury. In our hospital, we use a…”
Get full text
Journal Article -
7
少量補液負荷の胆道がんGemcitabine+Cisplatin療法の忍容性評価
Published in YAKUGAKU ZASSHI (01-07-2020)“…「緒言」 胆道がんの治療法は, 外科的切除術により根治を期待できるが, 切除不能例や切除後再発例では, 生存期間の延長を目的にがん薬物療法が行われる. 胆道がん薬物療法は, 英国で2009年に行われた第III相臨床試験より,…”
Get full text
Journal Article -
8
Dexamethasone-sparing on days 2–4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial)
Published in British journal of cancer (10-02-2024)“…Background This study evaluated the non-inferiority of dexamethasone (DEX) on day 1, with sparing on days 2–4 in cisplatin-based chemotherapy. Methods Patients…”
Get full text
Journal Article -
9
-
10
Active Adult Learning患者担当制病棟実習(Patient Oriented Clerkship)の学習者情動への影響
Published in YAKUGAKU ZASSHI (01-11-2011)Get full text
Journal Article -
11
A cross-sectional survey of methods for controling hand-foot syndrome in patients receiving capecitabine treatment
Published in Molecular and clinical oncology (01-10-2018)“…Medical personnel actively provide patients taking capecitabine with information on the items to prevent and treat hand-foot syndrome (HFS). However, they are…”
Get full text
Journal Article -
12
-
13
Effect of the Active Adult Learning/Patient Oriented Clerkship on Affective Reaction of Students ∼From the Results of Student Survey
Published in YAKUGAKU ZASSHI (01-11-2011)“…We have previously reported the efficacy of the Patient Oriented Clerkship (POC) in the clinical clerkship in Showa University Hospitals, by a trial with old…”
Get full text
Journal Article -
14
-
15